Cybin Inc. Files 6-K, Reacts to FDA Commission
Ticker: HELP · Form: 6-K · Filed: May 20, 2025 · CIK: 1833141
| Field | Detail |
|---|---|
| Company | Cybin INC. (HELP) |
| Form Type | 6-K |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, news-release, FDA
TL;DR
CYBIN files 6-K, positive FDA news incoming?
AI Summary
Cybin Inc. filed a Form 6-K on May 20, 2025, reporting a news release dated May 20, 2025. The news release, attached as Exhibit 99.1, concerns Cybin's positive reaction to an FDA commission. The company is incorporated in A6 and its principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.
Why It Matters
This filing indicates Cybin Inc. is actively engaging with regulatory bodies like the FDA, which could impact its drug development and approval timelines.
Risk Assessment
Risk Level: medium — The filing is a routine report, but the nature of the FDA commission and its implications for Cybin's pipeline introduce a moderate level of uncertainty.
Key Numbers
- 001-40673 — SEC File Number (Identifies the specific SEC filing series for Cybin Inc.)
Key Players & Entities
- CYBIN INC. (company) — Registrant
- Doug Drysdale (person) — Chief Executive Officer
- FDA (company) — Regulatory Body
- May 20, 2025 (date) — Filing Date and News Release Date
- 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (location) — Principal Executive Offices
FAQ
What specific FDA commission is Cybin Inc. reacting to?
The filing does not specify the exact nature of the FDA commission, only that Cybin Inc. 'Applauds FDA Commission' in Exhibit 99.1.
What is the significance of the news release dated May 20, 2025?
The news release, attached as Exhibit 99.1, is the primary subject of this 6-K filing and details Cybin Inc.'s positive response to an FDA commission.
What is Cybin Inc.'s fiscal year end?
Cybin Inc.'s fiscal year ends on March 31st (0331).
Where are Cybin Inc.'s principal executive offices located?
Cybin Inc.'s principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.
Who signed the Form 6-K on behalf of Cybin Inc.?
Doug Drysdale, Chief Executive Officer, signed the Form 6-K on behalf of Cybin Inc.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 20, 2025 by Doug Drysdale regarding CYBIN INC. (HELP).